| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +43,907 | 100% | $0.9138 | +$40,123 |
| Sells | 0 | ||||
| Net | +5 | +43,907 | 100% | +$40,123 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David A. Dodd | President, CEO, Director | $39,594 | +$10,800 | +38% | 05 Jun 2025 |
| Mark W. Reynolds | Cfo | $15,133 | +$7,343 | +94% | 05 Jun 2025 |
| John N. Spencer Jr. | Director | $11,766 | +$15,298 | 17 Oct 2025 | |
| John Sharkey | VP, Business Development | $6,129 | +$5,940 | +3143% | 05 Jun 2025 |
| Kelly T. McKee | Chief Medical Officer | $2,340 | +$742 | +46% | 07 Aug 2025 |
| Dean Kollintzas | Director | 05 Jun 2025 | |||
| Mark Newman | Chief Scientific Officer | 05 Jun 2025 | |||
| Randal Chase | Director | 05 Jun 2025 | |||
| Nicole Lemerond | Director | 05 Jun 2025 | |||
| Robert McNally | Director | 05 Jun 2025 | |||
| Jayne Morgan | Director | 05 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|